Alexion Pharmaceuticals, Inc. (ALXN) Social Stream



Alexion Pharmaceuticals, Inc. (ALXN): $182.50

3.05 (+1.70%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ALXN to Watchlist
Sign Up

Industry: Biotech


Ranked

of 498

in industry

Featured Post From StockTwits About ALXN

$AZN $ALXN Shares of AstraZeneca have gained +14% in the past three months against the Zacks Large Cap Pharmaceuticals industry’s gain of +10%. The Zacks analyst believes that AstraZeneca’s newer drugs, mainly cancer medicines Lynparza, Tagrisso and Imfinzi should keep driving revenues.

It has a strong pipeline with a number of phase III data readouts lined up for this year. Numerous external acquisitions and strategic collaborations are likely to boost AstraZeneca’s pipeline. The company has a record of earnings surprises in the recent quarters.
streamwars, published July 16, 2021

What Else are ALXN Traders Talking About?


Other tickers frequently mentioned alongside ALXN is AZN.

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7748 seconds.